Lite Strategy, Inc. (LITS)
1.06
+0.02
(+1.92%)
USD |
NASDAQ |
Sep 03, 11:20
Lite Strategy Net Income (Annual) : -15.94M for June 30, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| June 30, 2025 | -15.94M |
| June 30, 2024 | 17.78M |
| June 30, 2023 | -31.84M |
| June 30, 2022 | -54.45M |
| June 30, 2021 | -41.31M |
| June 30, 2020 | -46.02M |
| June 30, 2019 | -16.82M |
| June 30, 2018 | -40.07M |
| June 30, 2017 | 2.67M |
| June 30, 2016 | -20.86M |
| June 30, 2015 | -32.69M |
| June 30, 2014 | -27.15M |
| Date | Value |
|---|---|
| June 30, 2013 | -11.19M |
| June 30, 2012 | -7.523M |
| June 30, 2011 | -6.781M |
| June 30, 2010 | -7.896M |
| June 30, 2009 | -11.18M |
| June 30, 2008 | -12.41M |
| June 30, 2007 | -13.82M |
| June 30, 2006 | -7.386M |
| June 30, 2005 | -6.421M |
| June 30, 2004 | -8.538M |
| June 30, 2003 | -3.033M |
| June 30, 2002 | -0.123M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| SELLAS Life Sciences Group, Inc. | -26.86M |
| ACADIA Pharmaceuticals, Inc. | 391.00M |
| Alnylam Pharmaceuticals, Inc. | 313.75M |
| Anika Therapeutics, Inc. | -9.979M |
| Savara, Inc. | -118.84M |